FDA Inspection 1321482 — Lilly Del Caribe, Inc.
The FDA completed an inspection of Lilly Del Caribe, Inc. on May 12, 2026 in Carolina, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 12, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Carolina, PR (United States)